Growth Financing BeatO has secured a significant Series B funding of 33 million led by Lightrock India with participation from HealthQuad, Flipkart and existing investors, signaling strong capital backing for expansion, tech investments, and scale of diabetes care programs.

Strategic Partnerships Active collaborations with IndiaMedToday, The Pharma Times, Educratsweb and IIHMR-Delhi through joint diabetes education initiatives present opportunities to integrate BeatO programs with academic, pharma, and health education channels for bundled offerings.

Omni Channel Wins Award recognition for Best Omni Channel Customer Experience Initiative indicates proven multi-channel engagement capabilities, suggesting sales pitches around seamless patient journeys across digital, telehealth, and partner channels.

Healthcare Expertise Led by diabetologists and certified diet coaches with clinically proven programs, BeatO can position enterprise solutions to clinics, corporates, and health systems seeking scalable diabetes prevention and management platforms.

Market Readiness Being India’s largest diabetes solutions platform with substantial user reach and a revenue base in the multi-million range, BeatO presents opportunities for white-label collaborations, SaaS-like platform licensing, or enterprise deployments to accelerate adoption in clinics and payers.